eXoZymes

Update in progress

EXOZ (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

eXoZymes, Inc. is a development-stage biotechnology company focused on creating enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. Formerly Invizyne Technologies, Inc., it renamed to eXoZymes in February 2025. The company was incorporated in 2014 and is based in Monrovia, California, with a mission to enable efficient, scalable biomanufacturing solutions.

Company score

Sentiment: 0.39; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.11; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.04; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.21; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive